CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 31 enrolled
Drug / intervention
Insulin Aspart +1 moredrug
Likely dose
Insulin Aspart 40IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00581867
NCT00581867Phase 2Completed
CompareCT.gov

Intranasal Insulin and Memory in Early Alzheimer's Disease

Jeff Burns, MD·interventional·Posted Dec 28, 2007·Updated Jul 14, 2015

In Brief

A Phase 2 clinical trial evaluating Insulin Aspart and Placebo for Alzheimer's Disease. Completed, enrolled 31 participants across 1 site.

Detailed Summary

To determine which parts of the brain are involved in insulin-related memory improvement in early Alzheimer's disease and cognitively normal older adults.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlzheimer's Disease
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 28, 2007
Enrollment StartOct 1, 2007
Primary CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 18.5 years ago

Interventions

Insulin Aspartdrug

40IU insulin aspart applied intranasally

Placebodrug

Placebo